ARWR vs CYTK: stock comparison and AI forecast
Arrowhead Pharmaceuticals, Inc. (ARWR) and Cytokinetics Inc (CYTK) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ARWR Arrowhead Pharmaceuticals, Inc.
- Price
- $60.49 -17.7% · 6M
- Market Cap
- $8.54B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
CYTK Cytokinetics Inc
- Price
- $62.31 -19.2% · 6M
- Market Cap
- $8.66B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ARWR and CYTK have similar market capitalizations ($8.54B and $8.66B).
- Over the last six months ARWR returned -17.7% and CYTK -19.2%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ARWR | CYTK |
|---|---|---|
| Market Cap | $8.54B | $8.66B |
| P/B Ratio | 18.35x | – |
| EPS | $-1.47 | $-7.23 |
| Book Value/Share | $3.30 | – |
| Revenue/Share | $6.63 | $0.50 |
| FCF/Share | $-0.53 | $-4.18 |
Profitability & Margins
| Metric | ARWR | CYTK |
|---|---|---|
| ROIC | -12.4% | – |
| Operating Margin | -24.2% | -944.8% |
| Net Margin | – | -933.0% |
| EBT Margin | -26.9% | -944.8% |
| Tax Rate | -8.0% | – |
Financial Health
| Metric | ARWR | CYTK |
|---|---|---|
| Current Ratio | 5.90x | 6.66x |
| Quick Ratio | – | 6.66x |
| D/E Ratio | 3.54x | – |
| Financial Leverage | 4.54x | – |
| Interest Coverage | -2321.4x | -16.9x |
| Working Capital | $1.39B | $1.03B |
Cash Flow
| Metric | ARWR | CYTK |
|---|---|---|
| Operating Cash Flow | -$59M | -$555M |
| Free Cash Flow | -$75M | -$581M |
| Capital Spending | -$16M | -$25M |
| OCF Growth YoY | -370.3% | – |
| FCF/Sales | -8.0% | -838.6% |
| CapEx/Sales | 1.7% | 36.5% |
Operational Efficiency
| Metric | ARWR | CYTK |
|---|---|---|
| Asset Turnover | 0.44x | – |
| Receivables Turnover | 109.4x | 2.8x |
| Fixed Assets Turnover | 2.5x | 0.9x |
| Days Sales Outstanding | 3 days | 129 days |
Income Statement
| Metric | ARWR | CYTK |
|---|---|---|
| Total Revenue | $936M | $69M |
| Operating Income | -$226M | -$708M |
| Net Income | – | -$699M |
| R&D Expense | $723M | $397M |
Dividend & Shareholder Information
| Metric | ARWR | CYTK |
|---|---|---|
| Shares Outstanding | 141M | 139M |
ARWR vs CYTK: stock comparison and AI forecast
Which is bigger, ARWR or CYTK?
ARWR and CYTK have similar market capitalizations ($8.54B and $8.66B).
Which stock performed better over the last six months, ARWR or CYTK?
Over the last six months ARWR returned -17.7% and CYTK -19.2%.
Which one does Intratio's AI model rank higher, ARWR or CYTK?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.